HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Real-world data of six patients with atypical hemolytic uremic syndrome switched to ravulizumab.

AuthorsRasmus Ehren, Sandra Habbig
JournalPediatric nephrology (Berlin, Germany) (Pediatr Nephrol) Vol. 36 Issue 10 Pg. 3281-3282 (10 2021) ISSN: 1432-198X [Electronic] Germany
PMID34274988 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • ravulizumab
Topics
  • Antibodies, Monoclonal, Humanized
  • Atypical Hemolytic Uremic Syndrome (drug therapy, genetics)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: